Biotech company BioMarin Pharmaceutical (NASDAQ:BMRN) reported Q4 CY2025 results , with sales up 17% year on year to $874.6 ...

Pharmaceutical innovation exists to improve patient outcomes. Yet between laboratory discovery and patient benefit lies a ...

We're sharing an informative ranking of the 10 largest pharmaceutical companies in the world, comparing prescription sales ...

The company reaffirmed its guidance for 2025, projecting Jornay PM net revenue to exceed $135 million, reflecting at least 34% annual growth. Management expects the expanded sales force to ...

Total GAAP revenue reached $15.7 million in Q2 2025, outpacing the $13.8 million GAAP analyst estimate. Selling, general and administrative expenses (GAAP) rose to $54.3 million, driving a net loss ...

With sluggish pharmaceutical sales in the third quarter coming in below analysts’ expectations, Bayer is acutely aware of the challenges facing its key unit. Nevertheless, at least as far as ...

LONDON--(BUSINESS WIRE)--As coronavirus continues to wreak havoc across industries, Quantzig’s sales analytics experts analyze the recent challenges in the pharmaceutical industry and explain why a ...

Pharmaceutical sales in the UK are undergoing a gradual but meaningful shift in who represents medicines to healthcare ...

The latest announcement is out from Solasia Pharma KK ( (JP:4597)). Solasia Pharma K.K. has announced a change in its sales partner for the oral liquid product, episil, in China. The company is ...